Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 607

1.

Innovations for the elimination and control of visceral leishmaniasis.

Selvapandiyan A, Croft SL, Rijal S, Nakhasi HL, Ganguly NK.

PLoS Negl Trop Dis. 2019 Sep 19;13(9):e0007616. doi: 10.1371/journal.pntd.0007616. eCollection 2019 Sep. No abstract available.

2.

Artificial Intelligence and Deep Learning: The Future of Medicine and Medical Practice.

Sanal MG, Paul K, Kumar S, Ganguly NK.

J Assoc Physicians India. 2019 Apr;67(4):71-73.

PMID:
31309802
3.

Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.

Islam MT, Chowdhury F, Qadri F, Sur D, Ganguly NK.

Vaccine. 2019 Jul 10. pii: S0264-410X(19)30870-9. doi: 10.1016/j.vaccine.2019.06.082. [Epub ahead of print]

4.

Opportunities and challenges for cholera control in India.

Gupta SS, Ganguly NK.

Vaccine. 2019 Jun 29. pii: S0264-410X(19)30794-7. doi: 10.1016/j.vaccine.2019.06.032. [Epub ahead of print]

5.

Malaria control in India: A national perspective in a regional and global fight to eliminate malaria.

Guerin PJ, Dhorda M, Ganguly NK, Sibley CH.

J Vector Borne Dis. 2019 Jan-Mar;56(1):41-45. doi: 10.4103/0972-9062.257773. Review.

6.

Cholera prevention and control in Asian countries.

Ahmed MU, Baquilod M, Deola C, Tu ND, Anh DD, Grasso C, Gautam A, Hamzah WM, Heng S, Iamsirithaworn S, Kadim M, Kar SK, Le Thi Quynh M, Lopez AL, Lynch J, Memon I, Mengel M, Long VN, Pandey BD, Quadri F, Saadatian-Elahi M, Gupta SS, Sultan A, Sur D, Tan DQ, Ha HTT, Hein NT, Lan PT, Upreti SR, Endtz H, Ganguly NK, Legros D, Picot V, Nair GB.

BMC Proc. 2018 Dec 7;12(Suppl 13):62. doi: 10.1186/s12919-018-0158-1. eCollection 2018.

7.

Can India lead the way in neglected diseases innovation?

Thomas Z, Saha GK, Gopakumar KM, Ganguly NK.

BMJ. 2019 Jan 22;364:k5396. doi: 10.1136/bmj.k5396. No abstract available.

8.

A Retrospective Review of Hospital-Based Data on Enteric Fever in India, 2014-2015.

Sur D, Barkume C, Mukhopadhyay B, Date K, Ganguly NK, Garrett D.

J Infect Dis. 2018 Nov 10;218(suppl_4):S206-S213. doi: 10.1093/infdis/jiy502.

9.

Q-Rich Yeast Prion [PSI+] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein.

Verma M, Girdhar A, Patel B, Ganguly NK, Kukreti R, Taneja V.

Front Mol Neurosci. 2018 Mar 13;11:75. doi: 10.3389/fnmol.2018.00075. eCollection 2018.

10.

Expression analysis of protein homeostasis pathways in the peripheral blood mononuclear cells of sporadic amyotrophic lateral sclerosis patients.

Vats A, Gourie-Devi M, Ahuja K, Sharma A, Wajid S, Ganguly NK, Taneja V.

J Neurol Sci. 2018 Apr 15;387:85-91. doi: 10.1016/j.jns.2018.01.035. Epub 2018 Jan 31.

PMID:
29571878
11.

India's March to Halt the Emerging Cardiovascular Epidemic.

Sharma M, Kartha CC, Mukhopadhyay B, Goyal RK, Gupta SK, Ganguly NK, Dhalla NS.

Circ Res. 2017 Sep 29;121(8):913-916. doi: 10.1161/CIRCRESAHA.117.310904. No abstract available.

PMID:
28963188
12.

Identification of burden hotspots and risk factors for cholera in India: An observational study.

Ali M, Sen Gupta S, Arora N, Khasnobis P, Venkatesh S, Sur D, Nair GB, Sack DA, Ganguly NK.

PLoS One. 2017 Aug 24;12(8):e0183100. doi: 10.1371/journal.pone.0183100. eCollection 2017.

13.

Analysis of C9orf72 repeat expansion in amyotrophic lateral sclerosis patients from North India.

Vats A, Gourie-Devi M, Suroliya V, Verma S, Faruq M, Sharma A, Ganguly NK, Kukreti R, Wajid S, Taneja V.

J Neurol Sci. 2017 Feb 15;373:55-57. doi: 10.1016/j.jns.2016.11.079. Epub 2016 Dec 5.

PMID:
28131227
14.

Prof. Gursharan Singh Chhatwal: an exceptional Punjabi Scientist.

Ganguly NK.

Environ Microbiol Rep. 2016 Oct;8(5):558. doi: 10.1111/1758-2229.12472. No abstract available.

PMID:
30240167
15.

Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.

Gupta SS, Bharati K, Sur D, Khera A, Ganguly NK, Nair GB.

Indian J Med Res. 2016 May;143(5):545-51. doi: 10.4103/0971-5916.187102. No abstract available.

16.

Gut microbiome, gut function, and probiotics: Implications for health.

Hajela N, Ramakrishna BS, Nair GB, Abraham P, Gopalan S, Ganguly NK.

Indian J Gastroenterol. 2015 Mar;34(2):93-107. doi: 10.1007/s12664-015-0547-6. Epub 2015 Apr 29. Review.

PMID:
25917520
17.

Streptococcal pharyngitis, rheumatic fever and rheumatic heart disease: Eight-year prospective surveillance in Rupnagar district of Punjab, India.

Kumar R, Sharma YP, Thakur JS, Patro BK, Bhatia A, Singh IP, Rana SK, Chakraborti A, Dhanda V, Sapru S, Sharma M, Shah B, Ganguly NK.

Natl Med J India. 2014 Mar-Apr;27(2):70-5.

PMID:
25471757
18.

Biomedicine and biotechnology: public health impact.

Ganguly NK, Croft S, Singh L, Sinha S, Balganesh T.

Biomed Res Int. 2014;2014:524785. doi: 10.1155/2014/524785. Epub 2014 Apr 8. No abstract available.

19.

A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.

Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2014 May 5;9(5):e96367. doi: 10.1371/journal.pone.0096367. eCollection 2014.

20.

Probiotic foods: can their increasing use in India ameliorate the burden of chronic lifestyle disorders?

Hajela N, Nair GB, Ramakrishna BS, Ganguly NK.

Indian J Med Res. 2014 Jan;139(1):19-26. Review.

21.

A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.

Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2013 Sep 6;8(9):e73579. doi: 10.1371/journal.pone.0073579. eCollection 2013.

22.

Vaccine development and deployment: opportunities and challenges in India.

Gupta SS, Nair GB, Arora NK, Ganguly NK.

Vaccine. 2013 Apr 18;31 Suppl 2:B43-53. doi: 10.1016/j.vaccine.2012.11.079. Review.

PMID:
23598492
23.
24.

Does India need an indigenous HPV vaccine and why?

Bharati K, Ganguly NK.

J Public Health Policy. 2013 May;34(2):272-87. doi: 10.1057/jphp.2013.4. Epub 2013 Feb 28.

PMID:
23447031
25.

Deaths from symptomatically identifiable furious rabies in India: a nationally representative mortality survey.

Suraweera W, Morris SK, Kumar R, Warrell DA, Warrell MJ, Jha P; Million Death Study Collaborators.

PLoS Negl Trop Dis. 2012;6(10):e1847. doi: 10.1371/journal.pntd.0001847. Epub 2012 Oct 4.

26.

A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological results.

Lagrange PH, Thangaraj SK, Dayal R, Despande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2012;7(8):e43739. doi: 10.1371/journal.pone.0043739. Epub 2012 Aug 24.

27.

Suicide mortality in India: a nationally representative survey.

Patel V, Ramasundarahettige C, Vijayakumar L, Thakur JS, Gajalakshmi V, Gururaj G, Suraweera W, Jha P; Million Death Study Collaborators.

Lancet. 2012 Jun 23;379(9834):2343-51. doi: 10.1016/S0140-6736(12)60606-0.

28.

Health impact of probiotics - vision and opportunities.

Hajela N, Nair GB, Abraham P, Ganguly NK.

Gut Pathog. 2012 Mar 12;4(1):1. doi: 10.1186/1757-4749-4-1.

29.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18.

30.

Rationalizing antibiotic use to limit antibiotic resistance in India.

Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U, Hossain S, Joglekar S, Joshi PC, Kakkar M, Kotwani A, Rattan A, Sudarshan H, Thomas K, Wattal C, Easton A, Laxminarayan R; Global Antibiotic Resistance Partnership (GARP) - India Working Group.

Indian J Med Res. 2011 Sep;134:281-94.

31.

State of the Globe: The Immunological Quest for an HIV/AIDS Vaccine Continues.

Ganguly N.

J Glob Infect Dis. 2011 Jul;3(3):209-10. doi: 10.4103/0974-777X.83523. No abstract available.

32.

ICMR-DBT guidelines for evaluation of probiotics in food.

Indian Council of Medical Research Task Force; Co-ordinating Unit ICMR; Co-ordinating Unit DBT.

Indian J Med Res. 2011 Jul;134:22-5.

33.

India's vaccine deficit: why more than half of Indian children are not fully immunized, and what can--and should--be done.

Laxminarayan R, Ganguly NK.

Health Aff (Millwood). 2011 Jun;30(6):1096-103. doi: 10.1377/hlthaff.2011.0405. Erratum in: Health Aff (Millwood). 2012 Jan;31(1):252.

PMID:
21653963
34.

Cholera toxin: a paradigm of a multifunctional protein.

Bharati K, Ganguly NK.

Indian J Med Res. 2011 Feb;133:179-87. Review.

35.

The cell based therapy and the policy implications in India.

Mukhopadhyay B, Basak SK, Ganguly NK.

J Stem Cells. 2011;6(3):155-79. Review.

PMID:
23264999
36.

Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?

Hajela N, Nair GB, Ganguly NK.

Gut Pathog. 2010 Aug 29;2(1):10. doi: 10.1186/1757-4749-2-10.

37.

Natural prevalence of antibody titers to glucosyltransferase of Streptococcus mutans in serum in high and low caries active children.

Kirtaniya BC, Chawla HS, Tiwari A, Ganguly NK, Sachdev V.

J Indian Soc Pedod Prev Dent. 2010 Apr-Jun;28(2):91-4. doi: 10.4103/0970-4388.66744.

38.

Multi-center surveillance for pneumonia & meningitis among children (<2 yr) for Hib vaccine probe trial preparation in India.

Gupta M, Kumar R, Deb AK, Bhattacharya SK, Bose A, John J, Balraj V, Ganguly NK, Kant L, Kapoor AN, Watt J, Shearer J, Santosham M; Hib study working group.

Indian J Med Res. 2010 May;131:649-58.

39.

HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes.

Jha P, Kumar R, Khera A, Bhattacharya M, Arora P, Gajalakshmi V, Bhatia P, Kam D, Bassani DG, Sullivan A, Suraweera W, McLaughlin C, Dhingra N, Nagelkerke N; Million Death Study Collaborators.

BMJ. 2010 Feb 23;340:c621. doi: 10.1136/bmj.c621.

40.

Oral cholera vaccines--a call for action.

Sur D, Nair GB, Lopez AL, Clemens JD, Katoch VM, Ganguly NK.

Indian J Med Res. 2010 Jan;131:1-3. No abstract available.

PMID:
20167966
41.

Epidemiology of group A streptococcal pharyngitis & impetigo: a cross-sectional & follow up study in a rural community of northern India.

Kumar R, Vohra H, Chakraborty A, Sharma YP, Bandhopadhya S, Dhanda V, Sagar V, Sharma M, Shah B, Ganguly NK.

Indian J Med Res. 2009 Dec;130(6):765-71.

PMID:
20090140
42.

Natural prevalence of antibody titres to GTF of S. mutans in saliva in high and low caries active children.

Kirtaniya BC, Chawla HS, Tiwari A, Ganguly NK, Sachdev V.

J Indian Soc Pedod Prev Dent. 2009 Jul-Sep;27(3):135-8. doi: 10.4103/0970-4388.57092.

43.

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.

Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD.

Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8. Erratum in: Lancet. 2010 Oct 23;376(9750):1392.

PMID:
19819004
44.

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD.

N Engl J Med. 2009 Jul 23;361(4):335-44. doi: 10.1056/NEJMoa0807521.

45.
46.

Preparedness for AIDS vaccine trials in India.

Excler JL, Kochhar S, Kapoor S, Das S, Bahri J, Ghosh MD, Ganguly NK, Nayyar A, Chataway M.

Indian J Med Res. 2008 Jun;127(6):531-8. Review.

PMID:
18765870
47.

Genotyping of group A streptococcus by various molecular methods.

Nandi S, Ganguly NK, Kumar R, Bakshi DK, Vivek Sagar VS, Chakraborti A.

Indian J Med Res. 2008 Jan;127(1):71-7.

PMID:
18316856
48.

A nationally representative case-control study of smoking and death in India.

Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, Sinha DN, Dikshit RP, Parida DK, Kamadod R, Boreham J, Peto R; RGI-CGHR Investigators.

N Engl J Med. 2008 Mar 13;358(11):1137-47. doi: 10.1056/NEJMsa0707719. Epub 2008 Feb 13.

49.

Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.

Verma A, Sharma S, Ganguly NK, Majumdar S, Guptasarma P, Luthra-Guptasarma M.

Int J Biochem Cell Biol. 2008;40(4):663-76. Epub 2007 Oct 13.

PMID:
18023239
50.

Public health. Biobanks in developing countries: needs and feasibility.

Sgaier SK, Jha P, Mony P, Kurpad A, Lakshmi V, Kumar R, Ganguly NK.

Science. 2007 Nov 16;318(5853):1074-5. No abstract available.

PMID:
18006727

Supplemental Content

Loading ...
Support Center